Therapeutics and the part they play in the fight against COVID
“If you can have something by mouth that can quickly be taken and can, at least in the case of the Pfizer candidate, truly decrease hospitalization by 89% in someone who is high-risk, you are really defanging the virus,” Dr. Nahid Bhadelia says.
“We are seeing innovative ways for how people are getting monoclonal antibodies to patients, including drive-up windows, drive-up service and treatment in people’s own homes,” Dr. Preeti Malani says.
Today, On Point: Therapeutics and the part they’ll play in the fight against COVID-19.
Alice Carter, Boston-based professor of psychology, treated for COVID with monoclonal antibodies.
This article was originally published on WBUR.org.
Copyright 2021 NPR. To see more, visit https://www.npr.org.